RGC
GSK icon

Roberts, Glore & Co’s GSK GSK Stock Holding History

Roberts, Glore & Co’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4,460
Closed -$256K – 141
2014
Q3 		$256K Buy
4,460
+688
+18% +$42.2K 0.18% 120
2014
Q2 		$252K Sell
3,772
-8
-0.2% -$541 0.17% 123
2014
Q1 		$252K Hold
3,780
– – 0.17% 122
2013
Q4 		$252K Buy
3,780
+200
+6% +$13K 0.17% 120
2013
Q3 		$225K Sell
3,580
-1,960
-35% -$126K 0.17% 124
2013
Q2 		$346K Buy
+5,540
New +$352K 0.21% 107

Other funds holding GSK

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Roberts, Glore & Co's GSK Position: Q4 2014 in Review

Roberts, Glore & Co sold out of GSK (GSK) in Q4 2014, closing a stake of 4,460 shares — an estimated $256K sold.

Roberts, Glore & Co first reported a position in GSK in Q2 2013 and held it in 6 quarters. The position peaked at $346K in Q2 2013. 729 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

  • Roberts, Glore & Co reported no remaining GSK position as of Q4 2014 after selling out during the quarter.
  • Roberts, Glore & Co sold 4,460 GSK shares in Q4 2014, an estimated $256K.
  • Roberts, Glore & Co first reported a position in GSK in Q2 2013 and held it in 6 quarters.
  • Roberts, Glore & Co's GSK position peaked at $346K in Q2 2013.
  • 729 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on Roberts, Glore & Co's 13F filing for Q4 2014, filed 9 Feb 2015.